Vai al contenuto| Home page|

   Ti trovi in: HOME »Programmi, progetti e risultati »I progetti »FIRB - Fondo per gli Investimenti della Ricerca di Base »FIRB
INIZIO_TESTO_DA_INDICIZZARE

Fund for investing in fundamental research

italiano - inglese
Research Units
  • Universita' degli Studi di ROMA "La Sapienza"
    Dip. MEDICINA SPERIMENTALE E PATOLOGIA , ROMA (RM)
  • Universita' degli Studi di ROMA "La Sapienza"
    Dip. ISTOLOGIA ED EMBRIOLOGIA MEDICA , ROMA (RM)
  • Universita' Cattolica del Sacro Cuore
    Ist. Cardiologia , MILANO (MI)
  • Universita' degli Studi di MILANO
    Dip. SCIENZE FARMACOLOGICHE , MILANO (MI)
  • Universita' degli Studi di ROMA "La Sapienza"
    Dip. MEDICINA SPERIMENTALE E PATOLOGIA , ROMA (RM)
  • Universita' degli Studi di ROMA "La Sapienza"
    SCIENZE NEUROLOGICHE , ROMA (RM)
  • Universita' degli Studi di ROMA "La Sapienza"
    Dip. MEDICINA SPERIMENTALE E PATOLOGIA , ROMA (RM)
  • Universita' Cattolica del Sacro Cuore
    Ist. Neurologia , MILANO (MI)
  • Universita' degli Studi di ROMA "La Sapienza"
    Dip. FISIOLOGIA UMANA E FARMACOLOGIA , ROMA (RM)
Similar FIRB:
Scientific and education field classification
International Patent Classification
  • CHEMISTRY; METALLURGY
    • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
      • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)
  • HUMAN NECESSITIES
    • MEDICAL OR VETERINARY SCIENCE; HYGIENE
      • PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (bringing into special physical form A61J [N: mechanical aspects]; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; compounds per se C01, C07, C08, C12N; soap compositions C11D; micro-organisms per se C12N) [C0203]
Geographical classification
Bibliografia
- Austin L, Bower JJ, Bennett TM, Lynch GS, Kapsa R, White JD, Barnard W, Gregorevic P, Byrne E: Leukemia inhibiting factor Ameliorates muscle fiber degeneration in the mdx mouse. Muscle Nerve 23(11): 1700-5, 2000.
- Azzouz M, Hottinger A, Paterna JC, Zurn AD, Aebischer P, Bueler H. Increased motoneuron survival and improved neuromuscolar function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2. Hum Mol Genet 9(5):803-11, 2000.
- Barlucchi L, Leri A, Dostal DE, Fiordaliso F, Tada H, Hintze TH, Kajstura J, Nadal-Ginard B, Anversa P. Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure. Circ Res. 2001 Feb 16;88(3):298-304.
- Baulieu EE, Schumacher M. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids, 65(10-11):605-12, 2000.
- Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: Evidence that human cardiac myocytes divide after myocardial infarction. NEJM, 344:1750-1757, 2001.
- Bjorklund A, Lindvall O. Self-repair in the brain. Nature, 405:951-5, 2000.
- Bjorklund A. Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp, 231:7-15, 2000.
- Blaveri K, Heslop L, Yu DS, Rosenblatt JD, Gross JG, Pertridge TA, Morgan JE: Patterns of repair of dystrophic mouse muscle:Studies on isolated fibers. Dev Dyn 216(3):244-56, 1999.
- Chinni C, De Niese MR, Tew DJ, Jenkins AL, Bottomley SP, Mackie EJ: Thrombin, a survival factor for cultured myoblasts. J Biol Chem, 274:9169-9174, 1999
- Clark RS, Kochanek PM, Watkins SC, Chen M, Dixon CE, Seidberg NA, Melick J, Loeffert JE, Nathaniel PD, Jin KL, Graham SH. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem, 74(2):740-53, 2000.
- Cohn RD and Campbell KP: Molecular Basis of Muscular Dysthophies. Muscle Nerve, 23:1456-1471, 2000.
- CONDORELLI G, RONCARATI R, ROSS J, PISANI A, STASSI G, TODARO M, TROCHA S, DRUSCO A, GU Y, RUSSO MA, FRATI G, JONES SP, LEFER DJ, NAPOLI C, AND CROCE CM. Heart-targeted overexpression of caspase-3 in mice increases infarct size and depresses cardiac function.
Proc Natl Acad Sci USA, 98:9977-9982, 2001
- Frustaci A, Perrone GA, Gentiloni N, Russo MA:
REVERSIBLE DILATED CARDIOMYOPATHY DUE TO GROWTH HORMONE DEFICIENCY.
Am J Cli Pathol, 97:503-511, 1992.
- Frustaci A, Gentiloni N and Russo MA:
Growth hormone in the treatment of dilated cardiomyopathy.
NEJM, 335:672-674, 1996.
- FRUSTACI A., CHIMENTI C., RICCI R., NATALE L, RUSSO M.A., DESNICK RJ. (2001). Galactose infusion therapies improves cardiac function in the cardiac of Fabry's disease. Two year experience ov chaperone-mediated enzyme enhancement.
New Engl J Med, 345:24-32, 2001
- Granholm AC. Oestrogen and nerve-growth factor-neuroprotection and repair in Alzheimer's disease. Expert Opin Investig Drugs, 9(4):685-94, 2000.
- Guttridge DC, Mayo MW, Madrid LW, Wang CY, Baldwin AS: NFkB-induced loss of MyoD mRNA: possible role in muscle decay and cachexia. Science, 289:2293-2294, 2000.
- Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest. 1987 Mar;79(3):970-7.
- Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A. 1988 Jan;85(2):339-43.
- Kajstura J, Fiordaliso F, Andreoli AM, Li B, Chimenti S, Medow MS, Limana F, Nadal-Ginard B, Leri A and Anversa P: IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II- mediated oxidative stress. Diabetes 50(6): 1414-1424, 2001.
- Keirsteadt HS. Stem cell transplantation into the central nervous system and the control of differentiation. J Neurosci Res, 63(3):233-6, 2001.
- Koenig HL, Gong WH, Pelissier P. Role of progesterone in peripheral nerve repair. Rev Reprod, 5(3):189-99, 2000.
- Lee Y, Nadal-Ginard B, Mahdavi V, Izumo S. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol Cell Biol. 1997 May;17(5):2745-55.
- Leri A, Liu Y, Wang X, Kajstura J , Malhotra A, Meggs LG, Anversa P. Overexpression of insulin-like growth factor-1 attenuates the myocyte renin-angiotensin system in transgenic mice. Circ Res 84(7):752-62, 1999.
- Li Q, Li B, Leri A, Jana KP, Liu Y, Kajstura J , Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after ifarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100(8):1991-9, 1997.
- Lompre AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem. 1984 May 25;259(10):6437-46.
- Mattson MP. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res, 886(1-2):47-53, 2000.
- McKoy G, Ashley W, Mander J, Yang SY, Williams N, Russell B, Goldspink: Expression of IGF-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physol, 516:583-592, 1999.
- Miller KJ, Thaloor D, Matteson S, Pavlath GK: Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol cell physiol 278(1): 174-81, 2000.
- Munz B, Wiedman M, Lochmuller H, Werner S: Cloning of novel injury-regulated genes. Implications for an important role of the muscle-specific protein skNAC inmuscle repair. J Biol Chem, 274(19):13305-10,1999.
- Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 1989 Dec;84(6):1693-700. Review.
- Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9.
- Perry VH, Anthony DC. Axon damage and repair in multiple sclerosis. Philos Trans R Soc Lond B Biol Sci, 354(1390):1641-7, 1999.
- Russell SD, Cambon N, Nadal-Ginard B, Whalen RG. Thyroid hormone induces a nerve-Independent precocious expression of fast myosin heavy chain mRNA in rat hindlimb skeletal muscle. J Biol Chem. 1988 May 5;263(13):6370-4.
- Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, Cronberg T, Isshiki A, Erickson HP, Fassler R. Plasm fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med, 7(3):324-30, 2001.
- Scolding N. Therapeutic strategies in multiple sclerosis. II.Long-term repair. Philos Trans R Soc Lond B Biol Sci, 354(1390):1711-20, 1999.
- Thaloor D, Miller KJ, Gephart J, Mitchell PO, Pavlath GK: Systemic administration of the NFkB inhibitor curcumin stimulates muscle regeneration after traumatic injury. Am J Physiol, 277:C320-329, 1999.
- Walsh CA: Neuroscience in the post-genome era: an overview. Trends in Neurosciences, 24:363-363, 2001.
- Yamashit K, Kajstura J ,Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, Webster KA: Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse heart overexpressing Insulin-like Growth Factor-1. Circ Res, 88:609-614, 2001.
- Zhu YZ, Chimon GN, Zhu YC, Lu Q, Li B, Hu HZ, Yap EH, Lee HS, Wong PT. Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats. Neuroreport 11(6):1191-4, 2000.
Keywords
Molecular repair; Myocardial failure; Skeletal muscle myopathies; Neurodegenerative diseases; Repair signalling; Repair DNA microarrays

Identification of signaling pathways involved in molecular repair and functional recovery of post-mitotic cells (myocardial and skeletal myocytes, and nerve cells). A pre-clinal and clinical study.

Università degli Studi di Roma "La Sapienza"
Abstract
Functional insufficiency of an organ is often due to cell death (through either necrosis or apoptosis). Repair and functional recovery are thus dependent on the generation of new cells. This type of repair occurs in tissues such as blood and epithelia that are capable of recruiting a sufficient number of stem cells to regenerate the missing cells. When damage is extensive, so that the regenerative capacity of the stem cells is exceeded, exogenous delivery of stem cells can be utilized, hence the recent interest in the biology and therapeutic application of in vitro amplified and differentiated stem cells.
However, there are tissues such as myocardium, skeletal muscle and nervous tissue, characterized by a highly specialised structure, in which cell regeneration does not occur, or is very rare. Here, the missing cells are replaced by fibrous tissue (fibrosis) and this result in a progressive and irreversible functional impairment. At the moment, it is thought that there are two main reasons for this inability: a limited capacity in recruiting a sufficient number of stem cells to the injured site at the right time; and above all, a poor anatomical and functional integration of exogenous, and probably also of endogenous, stem cells in these highly structured tissues. Since the pathologies of these tissues (cardiac insufficiency, degenerative myopathies, neurodegenerative diseases), when taken as a whole, are responsible for the majority of diseases and deaths of the>>>

Principal Investigator
MATTEO ANTONIO RUSSO, Universita' degli Studi di ROMA "La Sapienza"
Research Goal
Objectives and expected results.

The working hypothesis is that sublethal damages responsible for the loss of function in the myocardium, in the skeletal muscle and in the nervous tissue, could be repaired by restoring the molecular integrity following suitable signals able to activate the genes of the damaged molecules. This objective forces us to achieve a series of targets either to demonstrate that the hypothesis is right or concerning the immediate clinical applications suggested by the hypothesis. Some of these aims are preliminary; others can be pursued in parallel presuming, as suggested by many preliminary results, the exactness of the hypothesis. The targets are listed according to the priority, specifying their clinical or preclinical nature, describing them in brief, indicating theU R's that will pursue them and the strategies and/or methodologies that will be followed.


Figure 1: The Damage/Repair equation and pathways of repair.

1.- First aim: Defining the equation damage/repair in stable tissues.

-Nature of the aim: essentially cognitive (preclinical)
-Description: though in literature exist data on the homeostatic capacity to maintain the structure/function in a post-mitotic cell, there are not established parameters that can help in defining the equation damage/repair for the preservation of cardiac myocites, of skeletal muscle cells and of neurons. For that reason, one of>>>

Timescale
36 months